Article Information
History
- July 24, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xiao Jiang1,
- Fengyuan Hu1,
- Xueqing Zoe Zou1,
- Ali Abbasi1,
- Sri V. V. Deevi1,
- Santosh S. Atanur1,
- Amanda O’Neill1,
- Jen Harrow1,
- Margarete Fabre1,2,3,
- Quanli Wang4,
- Slavé Petrovski1,
- William Rae5,
- Oliver Burren1 and
- Katherine R. Smith1,*
- 1Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 2Department of Haematology, University of Cambridge, Cambridge, UK
- 3Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
- 4Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA
- 5Clinical Development – Neurology & Ophthalmology, Alexion Pharmaceuticals Inc, Boston, Massachusetts, USA
- ↵*Correspondence: katherine.smith1{at}astrazeneca.com